Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 2
1(16.7%)
6Total
N/A(5)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT01341769Not ApplicableWithdrawn

Blood Glucose and Insulin Responses to Snack Food Products

Role: collaborator

NCT01536860Not ApplicableCompleted

Glycemic Response Testing

Role: collaborator

NCT01682174Not ApplicableCompleted

Glycaemic Response to a Liquid Meal Tolerance Test

Role: collaborator

NCT01687569Not ApplicableCompleted

Glycaemic Responses to Cracker Snacks

Role: collaborator

NCT01536847Not ApplicableCompleted

Glycaemic Response Testing

Role: collaborator

NCT00981981Phase 2Completed

Effect of the Molecular Weight of Oat β-glucan on Its Ability to Lower Serum Cholesterol

Role: collaborator

All 6 trials loaded